Skip to main content
. 2024 Feb 23;42(14):1635–1645. doi: 10.1200/JCO.23.01199

TABLE 1.

Patient and Tumor Characteristics

Variable All Patients (N = 40,890) Hispanic (n = 3,267) NHA (n = 1,368) NHB (n = 9,672) NHW (n = 26,150) NHO (n = 433) P a P b
Age, years <.001 <.001
 <50, No. (%) 16,416 (40.1) 1,857 (56.8) 634 (46.3) 3,882 (40.1) 9,817 (37.5) 226 (52.2)
 ≥50, No. (%) 24,474 (59.9) 1,410 (43.2) 734 (53.7) 5,790 (59.9) 16,333 (62.5) 207 (47.8)
 Median (IQR) 53 (44-61) 47 (39-56) 51 (41-60) 52 (44-60) 54 (45-63) 49 (40-57) <.001 <.001
Charlson/Deyo comorbidity score, No. (%) <.001 <.001
 0 35,181 (86) 2,858 (87.5) 1,221 (89.3) 7,895 (81.6) 22,838 (87.3) 369 (85.2)
 1 4,528 (11.1) 332 (10.2) 135 (9.9) 1,391 (14.4) 2,621 (10) 49 (11.3)
 ≥2 1,181 (2.9) 77 (2.4) 12 (0.9) 386 (4) 691 (2.6) 15 (3.5)
Histology, No. (%) <.001 <.001
 Ductal 36,481 (89.2) 2,914 (89.2) 1,231 (90) 8,730 (90.3) 23,205 (88.7) 401 (92.6)
 Lobular 1,609 (3.9) 121 (3.7) 62 (4.5) 309 (3.2) 1,104 (4.2) 13 (3)
 Other 2,800 (6.8) 232 (7.1) 75 (5.5) 633 (6.5) 1,841 (7) 19 (4.4)
Grade, No. (%) <.001 <.001
 1 313 (0.8) 21 (0.6) 15 (1.1) 51 (0.5) 225 (0.9) 1 (0.2)
 2 5,407 (13.2) 359 (11) 188 (13.7) 1,039 (10.7) 3,759 (14.4) 62 (14.3)
 3 32,888 (80.4) 2,706 (82.8) 1,097 (80.2) 8,053 (83.3) 20,687 (79.1) 345 (79.7)
Clinical T-stage, No. (%) <.001 <.001
 cT0/is 139 (0.3) 12 (0.4) 2 (0.1) 33 (0.3) 91 (0.3) 1 (0.2)
 cT1 8,483 (20.7) 571 (17.5) 222 (16.2) 1,828 (18.9) 5,782 (22.1) 80 (18.5)
 cT2 21,718 (53.1) 1,730 (53) 811 (59.3) 4,963 (51.3) 13,973 (53.4) 241 (55.7)
 cT3 6,626 (16.2) 669 (20.5) 218 (15.9) 1,842 (19) 3,826 (14.6) 71 (16.4)
 cT4 3,924 (9.6) 285 (8.7) 115 (8.4) 1,006 (10.4) 2,478 (9.5) 40 (9.2)
Clinical N-stage, No. (%) <.001 <.001
 cN0 20,809 (50.9) 1,523 (46.6) 719 (52.6) 4,269 (44.1) 14,077 (53.8) 221 (51)
 cN1 15,058 (36.8) 1,273 (39) 499 (36.5) 3,986 (41.2) 9,143 (35) 157 (36.3)
 cN2 2,838 (6.9) 263 (8.1) 85 (6.2) 795 (8.2) 1,664 (6.4) 31 (7.2)
 cN3 2,185 (5.3) 208 (6.4) 65 (4.8) 622 (6.4) 1,266 (4.8) 24 (5.5)
Income level, No. (%) <.001 <.001
 <$48,000 USD 13,952 (34.1) 1,425 (43.6) 230 (16.8) 4,994 (51.6) 7,177 (27.4) 126 (29.1)
 ≥$48,000 USD 21,331 (52.2) 1,436 (44) 952 (69.6) 3,398 (35.1) 15,300 (58.5) 245 (56.6)
Education level, No. (%) <.001 <.001
 HS graduation rate ≤87% 15,555 (38) 2,032 (62.2) 443 (32.4) 5,339 (55.2) 7,588 (29) 153 (35.3)
 HS graduation rate >87% 19,736 (48.3) 829 (25.4) 739 (54) 3,054 (31.6) 14,895 (57) 219 (50.6)
Community type, No. (%) <.001 <.001
 Metro 35,137 (85.9) 3,090 (94.6) 1,311 (95.8) 8,820 (91.2) 21,556 (82.4) 360 (83.1)
 Urban 4,142 (10.1) 134 (4.1) 27 (2) 559 (5.8) 3,377 (12.9) 45 (10.4)
 Rural 511 (1.2) 11 (0.3) 5 (0.4) 81 (0.8) 401 (1.5) 13 (3)
Insurance status, No. (%) <.001 <.001
 Private 25,617 (62.6) 1,570 (48.1) 895 (65.4) 5,404 (55.9) 17,499 (66.9) 249 (57.5)
 Government 13,370 (32.7) 1,207 (36.9) 410 (30) 3,717 (38.4) 7,872 (30.1) 164 (37.9)
 None 1,429 (3.5) 440 (13.5) 50 (3.7) 431 (4.5) 490 (1.9) 18 (4.2)
Facility type, No. (%) <.001 <.001
 Academic/research 14,930 (36.5) 1,536 (47) 619 (45.2) 4,078 (42.2) 8,526 (32.6) 171 (39.5)
 Integrated network 9,286 (22.7) 612 (18.7) 288 (21.1) 2,157 (22.3) 6,137 (23.5) 92 (21.2)
 Comprehensive community 14,462 (35.4) 952 (29.1) 414 (30.3) 3,031 (31.3) 9,907 (37.9) 158 (36.5)
 Community 2,202 (5.4) 166 (5.1) 47 (3.4) 405 (4.2) 1,572 (6) 12 (2.8)
Facility location, No. (%) <.001 <.001
 Midwest 10,565 (25.8) 320 (9.8) 199 (14.5) 1,950 (20.2) 8,024 (30.7) 72 (16.6)
 Northeast 7,005 (17.1) 585 (17.9) 295 (21.6) 1,397 (14.4) 4,662 (17.8) 66 (15.2)
 South 17,363 (42.5) 1,354 (41.4) 369 (27) 5,904 (61) 9,570 (36.6) 166 (38.3)
 West 5,947 (14.5) 1,007 (30.8) 505 (36.9) 420 (4.3) 3,886 (14.9) 129 (29.8)

NOTE. Percentages may not add up to 100 because of rounding or missing values.

Abbreviations: HS, high school; N, node; NHA, Non-Hispanic Asian; NHB, Non-Hispanic Black; NHO, Non-Hispanic Other; NHW, Non-Hispanic White; T, tumor; USD, US dollars.

a

P value for comparison of all race/ethnicity groups.

b

P value for NHW versus NHB.